BPG is committed to discovery and dissemination of knowledge
Articles Published Processes
1/4/2023 5:53:01 AM | Browse: 207 | Download: 456
Publication Name World Journal of Gastroenterology
Manuscript ID 80301
Country/Territory United States
Received
2022-09-26 00:20
Peer-Review Started
2022-09-26 00:21
To Make the First Decision
Return for Revision
2022-10-18 07:41
Revised
2022-10-22 00:04
Second Decision
2022-12-12 03:31
Accepted by Journal Editor-in-Chief
Accepted by Company Editor-in-Chief
2022-12-14 00:15
Articles in Press
2022-12-14 00:15
Publication Fee Transferred
Edit the Manuscript by Language Editor
Typeset the Manuscript
2022-12-22 23:11
Publish the Manuscript Online
2023-01-04 05:53
ISSN 1007-9327 (print) and 2219-2840 (online)
Open Access This article is an open-access article that was selected by an in-house editor and fully peer-reviewed by external reviewers. It is distributed in accordance with the Creative Commons Attribution NonCommercial (CC BY-NC 4.0) license, which permits others to distribute, remix, adapt, build upon this work non-commercially, and license their derivative works on different terms, provided the original work is properly cited and the use is non-commercial. See: http://creativecommons.org/Licenses/by-nc/4.0/
Copyright ©The Author(s) 2022. Published by Baishideng Publishing Group Inc. All rights reserved.
Article Reprints For details, please visit: http://www.wjgnet.com/bpg/gerinfo/247
Permissions For details, please visit: http://www.wjgnet.com/bpg/gerinfo/207
Publisher Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA
Website http://www.wjgnet.com
Category Gastroenterology & Hepatology
Manuscript Type Review
Article Title Evolution of care in cirrhosis: Preventing hepatic decompensation through pharmacotherapy
Manuscript Source Invited Manuscript
All Author List Seohyuk Lee and Saad Saffo
ORCID
Author(s) ORCID Number
Seohyuk Lee http://orcid.org/0000-0003-3023-1304
Saad Saffo http://orcid.org/0000-0001-5375-3100
Funding Agency and Grant Number
Corresponding Author Saad Saffo, MD, Academic Fellow, Department of Medicine, Section of Digestive Diseases, Yale School of Medicine, 333 Cedar Street, 1080 LMP, New Haven, CT 06520-8019, United States. saad.saffo@yale.edu
Key Words Cirrhosis; Hepatic decompensation; Beta-blockers; Statins; Sodium-glucose cotransporter-2 inhibitors; Rifaximin
Core Tip Hepatic decompensation is the most important clinical predictor of morbidity and mortality among patients with cirrhosis. New pharmacotherapies aimed at preventing hepatic decompensation in high-risk patients are emerging, augmenting traditional management strategies. These treatments represent safe, accessible, and effective options that may improve quality of life and prolong transplant-free survival, regardless of the etiologic factors involved.
Publish Date 2023-01-04 05:53
Citation Lee S, Saffo S. Evolution of care in cirrhosis: Preventing hepatic decompensation through pharmacotherapy. World J Gastroenterol 2023; 29(1): 61-74
URL https://www.wjgnet.com/1007-9327/full/v29/i1/61.htm
DOI https://dx.doi.org/10.3748/wjg.v29.i1.61
Full Article (PDF) WJG-29-61.pdf
Full Article (Word) WJG-29-61.docx
Manuscript File 80301_Auto_Edited-LM.docx
Answering Reviewers 80301-Answering reviewers.pdf
Audio Core Tip 80301-Audio core tip.mp3
Conflict-of-Interest Disclosure Form 80301-Conflict-of-interest statement.pdf
Copyright License Agreement 80301-Copyright license agreement.pdf
Non-Native Speakers of English Editing Certificate 80301-Language certificate.pdf
Peer-review Report 80301-Peer-review(s).pdf
Scientific Misconduct Check 80301-Bing-Wang JJ-2.png
Scientific Editor Work List 80301-Scientific editor work list.pdf